Results 131 to 140 of about 5,138,951 (296)
Рациональная фармакотерапия в кардиологии, 2015 Aim. To evaluate the clinical results of thrombolytic therapy with thrombolytics (alteplase, tenecteplase) in patients with ST segment elevation myocardial infarction (STEMI). Material and methods.
L. A. Bondarenko +4 more
doaj +1 more source
Canadian Anaesthetists’ Society Journal, 1985 A, Bailey, J C, Lydon, F J, Spielman
openaire +2 more sources
Annals of Clinical and Translational Neurology, Volume 13, Issue 4, Page 819-826, April 2026.ABSTRACT Objective Plasma fibrinogen is essential in thrombosis and fibrinolysis, yet its dynamic changes pre‐ and post‐intravenous thrombolysis (IVT) for predicting brain injury severity and prognosis in acute ischemic stroke (AIS) patients remain unclear.
Wenhai Zhai +28 more
wiley +1 more source
پزشکی بالینی ابن سینا, 2005 Acute myocardial infarction (AMI ) is one of the most common cause of mortality in almost all countries of the world. According to this fact that thrombus formation and coronary obstruction are the basic pathophysiology of AMI , early thrombolysis and
Shahram Homayonfar +2 more
doaj
Advanced Healthcare Materials, Volume 15, Issue 14, 10 April 2026.Intranasally administered hUMSC‐derived exosomes modulate the CRYAB–ARRDC3–Drp1 axis, alleviating mitochondrial dysfunction and ferroptosis, enhancing neuronal survival, reducing oxidative stress, and promoting functional recovery in ischemia‐reperfusion injury, offering a promising therapeutic strategy for ischemic stroke.
Rong ji +7 more
wiley +1 more source
Advanced Science, Volume 13, Issue 23, 23 April 2026.CCR2‐Enhanced Macrophage Membrane–Camouflaged Microbubbles for MCP‐1–Mediated Thrombus Targeting and Ultrasound‐Triggered Urokinase Release. ABSTRACT The clinical management of thrombosis, a primary cause of death worldwide, is hampered by the limitations of current thrombolytic agents, including short half‐life and high risk of off‐target bleeding ...
Buying Li +8 more
wiley +1 more source
Alzheimer's &Dementia, Volume 22, Issue 4, April 2026.Abstract In 2011, a workgroup of the Alzheimer's Association Research Roundtable introduced recommendations for detecting and monitoring amyloid‐related imaging abnormalities (ARIA) in Alzheimer's disease (AD) clinical trials. Since then, anti‐amyloid immunotherapies have received regulatory approval for AD treatment and are beginning to enter clinical
Ellis S. van Etten +14 more
wiley +1 more source
Correction to “Ultrasound Trigger Ce‐Based MOF Nanoenzyme For Efficient Thrombolytic Therapy”
Advanced Science, EarlyView.
wiley +1 more source
Association of Eosinophil Counts and Ratios With Clinical Outcomes After Acute Ischemic Stroke
Brain and Behavior, Volume 16, Issue 4, April 2026.This study demonstrates for the first time that low peripheral eosinophil levels are independent predictors of adverse 5‐year outcomes in ischemic stroke or TIA patients, providing a novel basis for risk stratification and future mechanistic research.
Yangying Lu +12 more
wiley +1 more source
Clinical Case Reports, Volume 14, Issue 4, April 2026.ST segment elevation following adenosine administration in the inferior leads (II, III, aVF). ABSTRACT Adenosine, used to treat paroxysmal supraventricular tachycardia, commonly causes flushing, sweating, palpitations, and hypotension. Rarely, it may induce ST‐segment elevation with chest pain, suggesting transient myocardial ischemia or coronary ...
Sweta Singh +4 more
wiley +1 more source